
Peak Bio
Clinical-stage bio-pharmaceutical company focused on innovative therapeutics that address significant unmet medical need for patients with inflammatory, rare and specialty diseases, and cancer.
Market cap
$1.6m
Enterprise value
$14m
Share price
$0.02 PKBO
Authorizing premium user...